ECSP045255A - Cumarinas utiles como biomarcadores - Google Patents

Cumarinas utiles como biomarcadores

Info

Publication number
ECSP045255A
ECSP045255A EC2004005255A ECSP045255A ECSP045255A EC SP045255 A ECSP045255 A EC SP045255A EC 2004005255 A EC2004005255 A EC 2004005255A EC SP045255 A ECSP045255 A EC SP045255A EC SP045255 A ECSP045255 A EC SP045255A
Authority
EC
Ecuador
Prior art keywords
biomarkers
useful
roads
formula
compounds
Prior art date
Application number
EC2004005255A
Other languages
English (en)
Inventor
Yves Auberson
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9932424&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP045255(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ECSP045255A publication Critical patent/ECSP045255A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La invención proporciona compuestos de la fórmula (I), en donde R, R1, R2, R3, y R4 son como se definen en la descripción, y su preparación. Los compuestos de la fórmula I son útiles como biomarcadores.
EC2004005255A 2002-03-06 2004-08-27 Cumarinas utiles como biomarcadores ECSP045255A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0205281.9A GB0205281D0 (en) 2002-03-06 2002-03-06 Organic compounds

Publications (1)

Publication Number Publication Date
ECSP045255A true ECSP045255A (es) 2004-09-28

Family

ID=9932424

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2004005255A ECSP045255A (es) 2002-03-06 2004-08-27 Cumarinas utiles como biomarcadores

Country Status (24)

Country Link
US (1) US7569337B2 (es)
EP (1) EP1483262B1 (es)
JP (2) JP4247123B2 (es)
KR (1) KR20040095257A (es)
CN (1) CN1628114A (es)
AR (1) AR038723A1 (es)
AT (1) ATE378333T1 (es)
AU (1) AU2003210418A1 (es)
BR (1) BR0308211A (es)
CA (1) CA2472298A1 (es)
CO (1) CO5611123A2 (es)
DE (1) DE60317476T2 (es)
EC (1) ECSP045255A (es)
ES (1) ES2294304T3 (es)
GB (1) GB0205281D0 (es)
MX (1) MXPA04008570A (es)
NO (1) NO20044174L (es)
PE (1) PE20030890A1 (es)
PL (1) PL370916A1 (es)
PT (1) PT1483262E (es)
RU (1) RU2004129733A (es)
TW (1) TW200400049A (es)
WO (1) WO2003074519A1 (es)
ZA (1) ZA200405175B (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0205281D0 (en) * 2002-03-06 2002-04-17 Novartis Ag Organic compounds
WO2005040337A2 (en) * 2003-05-20 2005-05-06 The Regents Of The University Of California METHODS FOR BINDING AGENTS TO β-AMYLOID PLAQUES
JP2007084526A (ja) * 2004-11-26 2007-04-05 Nagasaki Univ アミロイド関連疾患診断用組成物
EP1815872A4 (en) 2004-11-26 2011-06-15 Univ Nagasaki COMPOSITION FOR THE DIAGNOSIS OF AMYLOID ASSOCIATED DISEASE
TW200803903A (en) * 2006-04-28 2008-01-16 Nihon Mediphysics Co Ltd Novel compound having affinity to amyloid
JP5238496B2 (ja) * 2006-05-19 2013-07-17 日本メジフィジックス株式会社 新規アミロイド親和性化合物
CA2655826A1 (en) * 2006-06-21 2007-12-27 Nihon Medi-Physics Co., Ltd. Novel compound having affinity for amyloid
TW200811175A (en) * 2006-06-21 2008-03-01 Nihon Mediphysics Co Ltd Novel compound with affinity with amyloid
JP5258583B2 (ja) 2007-02-13 2013-08-07 日本メジフィジックス株式会社 放射性画像診断剤の製造方法
KR20100091965A (ko) * 2007-10-24 2010-08-19 니혼 메디피직스 가부시키가이샤 신규 아밀로이드 친화성 화합물
CA2704139A1 (en) * 2007-10-30 2009-05-07 Nihon Medi-Physics Co., Ltd. Utilization of novel compounds with amyloid affinity and method of producing the same
CA2704172A1 (en) * 2007-10-30 2009-05-07 Nihon Medi-Physics Co., Ltd. Use of novel compound having affinity for amyloid, and process for production of the same
CN104244944B (zh) * 2011-12-30 2018-06-08 Ptc医疗公司 用于治疗脊髓性肌萎缩症的化合物
US9296728B2 (en) 2012-01-20 2016-03-29 Regents Of The University Of Minnesota Therapeutic compounds
EP2809322B9 (en) * 2012-01-26 2019-10-30 PTC Therapeutics, Inc. Compounds for treating spinal muscular atrophy
MX354074B (es) 2012-02-10 2018-02-12 Ptc Therapeutics Inc Compuestos para tratar la atrofia muscular espinal.
JP6092264B2 (ja) * 2012-03-01 2017-03-08 ピーティーシー セラピューティクス， インコーポレイテッド 脊髄性筋委縮症を処置するための化合物
CN104470909B (zh) 2012-03-23 2018-04-24 Ptc医疗公司 用于治疗脊髓性肌萎缩的化合物
CN103420990B (zh) * 2012-05-23 2016-04-20 复旦大学 7-氧、硫或氮杂取代香豆素及其衍生物和用途
US10195202B2 (en) 2013-12-19 2019-02-05 Ptc Therapeutics, Inc. Methods for modulating the amount of RNA transcripts
EP4249472A3 (en) 2015-05-30 2023-12-13 PTC Therapeutics, Inc. Methods for modulating rna splicing
MX391850B (es) 2015-12-10 2025-03-19 Ptc Therapeutics Inc Compuestos para usarse en el tratamiento o mejoramiento de la enfermedad de huntington
MX2019005588A (es) 2016-11-28 2019-10-15 Ptc Therapeutics Inc Metodos para modular corte y empalme de arn.
WO2018114710A1 (en) 2016-12-22 2018-06-28 Illumina Cambridge Limited Coumarin compounds and their uses as fluorescent labels
CN108061725B (zh) * 2017-02-16 2020-04-21 昆明医科大学 1,8-萘啶基荧光分子探针在氯胺酮娱乐性滥用神经机制研究及成瘾程度诊断中的应用
CA3066224A1 (en) 2017-06-05 2018-12-13 Ptc Therapeutics Inc. Compounds for treating huntington's disease
KR20200017476A (ko) 2017-06-14 2020-02-18 피티씨 테라퓨틱스, 인크. Rna 스플라이싱의 변경 방법
MX2019015580A (es) 2017-06-28 2020-07-28 Ptc Therapeutics Inc Metodos para tratar la enfermedad de huntington.
US11382918B2 (en) 2017-06-28 2022-07-12 Ptc Therapeutics, Inc. Methods for treating Huntington's Disease
JP7399870B2 (ja) 2018-03-27 2023-12-18 ピーティーシー セラピューティクス， インコーポレイテッド ハンチントン病を処置するための化合物
HUE068060T2 (hu) 2018-06-27 2024-12-28 Ptc Therapeutics Inc Heterociklikus és heteroaril vegyületek Huntington-kór kezelésére
US11685746B2 (en) 2018-06-27 2023-06-27 Ptc Therapeutics, Inc. Heteroaryl compounds for treating Huntington's disease
KR20210038845A (ko) 2018-06-27 2021-04-08 피티씨 테라퓨틱스, 인크. 헌팅턴병 치료를 위한 헤테로아릴 화합물
CA3103900A1 (en) * 2019-03-01 2020-09-10 Illumina Cambridge Limited Exocyclic amine substituted coumarin compounds and their uses as fluorescent labels
CN112300201B (zh) * 2020-12-07 2021-11-23 南京林业大学 一种三聚茚基香豆素-咔咯-卟啉四元体系星型化合物的合成及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH390250A (de) * 1958-06-19 1965-07-30 Geigy Ag J R Verfahren zur Herstellung von fluoreszierenden Farbstoffen
DE2065552A1 (de) * 1970-06-20 1974-03-07 Bayer Ag Oxazolyl-essigsaeurederivate
JPS5529110B2 (es) * 1972-12-25 1980-08-01
DE2410634A1 (de) * 1974-03-06 1975-09-18 Basf Ag 3-benzofurylcumarine
DE2411969A1 (de) * 1974-03-13 1975-09-25 Bayer Ag Farbstofflaser
DE2525986A1 (de) * 1975-06-11 1977-05-05 Bayer Ag Cumarinverbindungen
LU78311A1 (de) * 1977-10-13 1979-06-01 Ciba Geigy Ag Neue cumarinfarbstoffe,deren herstellung und verwendung
US4892922A (en) * 1987-11-30 1990-01-09 Eastman Kodak Company Polyester polymer containing the residue of a benzopyran colorant compound and shaped articles produced therefrom
JPH01169327A (ja) * 1987-12-25 1989-07-04 Mitsui Toatsu Chem Inc 紫外線検知用樹脂組成物
JP2999841B2 (ja) * 1991-04-03 2000-01-17 三井化学株式会社 発光スクリーン用樹脂組成物
ATE147400T1 (de) * 1991-08-13 1997-01-15 Bayer Ag Fluoreszierendes etikett
JPH073179A (ja) * 1993-06-15 1995-01-06 Nippon Kayaku Co Ltd インクジェットプリント用インク組成物及びこれを用いる染色法
JP4028155B2 (ja) * 2000-04-11 2007-12-26 日本カーバイド工業株式会社 蛍光性再帰反射シート
GB0205281D0 (en) * 2002-03-06 2002-04-17 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
ZA200405175B (en) 2005-06-21
MXPA04008570A (es) 2004-12-06
DE60317476T2 (de) 2008-05-21
AU2003210418A1 (en) 2003-09-16
JP2009102322A (ja) 2009-05-14
JP4247123B2 (ja) 2009-04-02
CO5611123A2 (es) 2006-02-28
ES2294304T3 (es) 2008-04-01
PL370916A1 (en) 2005-06-13
RU2004129733A (ru) 2005-06-27
GB0205281D0 (en) 2002-04-17
ATE378333T1 (de) 2007-11-15
PT1483262E (pt) 2008-02-11
BR0308211A (pt) 2004-12-21
DE60317476D1 (de) 2007-12-27
PE20030890A1 (es) 2003-12-05
JP2005526749A (ja) 2005-09-08
CN1628114A (zh) 2005-06-15
EP1483262A1 (en) 2004-12-08
WO2003074519A1 (en) 2003-09-12
TW200400049A (en) 2004-01-01
NO20044174L (no) 2004-09-30
CA2472298A1 (en) 2003-09-12
EP1483262B1 (en) 2007-11-14
AR038723A1 (es) 2005-01-26
US20050169837A1 (en) 2005-08-04
KR20040095257A (ko) 2004-11-12
US7569337B2 (en) 2009-08-04

Similar Documents

Publication Publication Date Title
ECSP045255A (es) Cumarinas utiles como biomarcadores
BR0313330A (pt) Piperidina-ftalazonas substituìdas com pirrolidinadiona como inibidores de pde4
DE60230890D1 (de) Indolizine als kinaseproteinhemmer
UY27729A1 (es) Inhibidores de quinasas.
PA8527001A1 (es) Poliarilcarboxamidas utiles como agentes reductores de lipidos
CR8986A (es) Isoxazoles sustituidos como fungicidas
CY1114284T1 (el) Σουλφονυλοπυρρολες ως hdac αναστολεις
BR0213140A (pt) Fungicidas de pirazol-pirimidina
BRPI0608886B8 (pt) derivados de n-sulfonilpirróis e seus usos
NO20071127L (no) Triazoloftalaziner
ECSP055863A (es) Piridodiacinas como funguicidas de plantas
CY1105137T1 (el) Παραγωγα αμινοκυκλοεξυλ αιθερων και χρησεις τους
DE50208918D1 (de) 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung
UY28694A1 (es) Nuevos compuestos
UY27902A1 (es) Derivados aldehido de polietilenglicol
ATE399168T1 (de) Imidazopyridin-derivate und ihre verwendung als induzierbare no-synthase inhibitoren
DE60311887D1 (de) Multifunktionelle kationische photoinitiatoren, deren herstellung und verwendung
ECSP044971A (es) Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson
EA200600601A1 (ru) Производные аминопиридина в качестве ингибиторов индуцируемой no-синтазы
EA200801365A1 (ru) Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины
BR0316544A (pt) Compostos calcilìticos
ECSP066275A (es) Piridinilanilidas
DE602004030231D1 (de) Pyrimidinonverbindungen als calcilytica
BRPI0414873A (pt) derivados de imidazopiridina como inibidores de no-sintase induzìveis
EA200400876A1 (ru) Способ получения производных толуола